Phase 1/1b study of lonafarnib and temozolomide in patients with recurrent or temozolomide refractory glioblastoma-Reference-Cited by-同舟云学术

Phase 1/1b study of lonafarnib and temozolomide in patients with recurrent or temozolomide refractory glioblastoma

Published:2013-04-30 Issue:15 Volume:119 Page:2747-2753
ISSN:0008-543X
Container-title:Cancer
language:en
Short-container-title:Cancer

Author:

Yust-Katz Shlomit¹,Liu Diane²,Yuan Ying²,Liu Vivien¹,Kang Sanghee¹,Groves Morris³,Puduvalli Vinay⁴,Levin Victor⁴,Conrad Charles¹,Colman Howard⁵,Hsu Sigmonid⁶,Yung W. K. Alfred¹,Gilbert Mark R.¹

Affiliation:

1. Department of Neuro-Oncology; University of Texas MD Anderson Cancer Center; Houston Texas

2. Department of Biostatistics; University of Texas MD Anderson Cancer Center; Houston Texas

3. Austin Brain Tumor Center; Austin Texas

4. Neuro-Oncology Program, Department of Neurosurgery and Neuroscience; Redwood City Hospital; Redwood City California

5. Department of Neurosurgery and Huntsman Cancer Institute; University of Utah; Salt Lake City Utah

6. The Vivian L. Smith Department of Neurosurgery, the University of Texas; Houston Texas

Publisher

Wiley

Subject

Cancer Research,Oncology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1002/cncr.28031/fullpdf

Reference21 articles.

1. Radiotherapy plus concomitant and adjuvant temozolmide for glioblastoma;Stupp;N Engl J Med,2005

2. Meta-analysis of radiation therapy with and without adjuvant chemotherapy for malignant gliomas in adults;Fine;Cancer,1993

3. Safety and feasibility of long-term temozolomide treatment in patients with high-grade glioma;Hau;Neurology,2007

4. A phase II study of temozolomide vs procarbazine in patients with glioblastoma multiforme in first relapse;Yung;Br J Cancer,2000

5. Temozolomide rechallenge in recurrent malignant glioma by using a continuous temozolomide schedule: the “rescue” approach;Perry;Cancer,2008

Cited by 32 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Autophagic-Related Proteins in Brain Gliomas: Role, Mechanisms, and Targeting Agents;Cancers;2023-05-05

2. Farnesyltransferase inhibitor LNK-754 attenuates axonal dystrophy and reduces amyloid pathology in mice;Molecular Neurodegeneration;2022-08-20

3. The impact of temozolomide and lonafarnib on the stemness marker expression of glioblastoma cells in multicellular spheroids;Biotechnology Progress;2022-07-10

4. The Identification of Necroptosis-Related Subtypes, the Construction of a Prognostic Model, and the Characterization of the Tumor Microenvironment in Gliomas;Frontiers in Oncology;2022-06-02

5. Combinatorial Strategies to Target Molecular and Signaling Pathways to Disarm Cancer Stem Cells;Frontiers in Oncology;2021-07-26